美国 · SEC FORM 4
BIODESIX INC
BDSX · Nasdaq · CIK 0001439725 · Healthcare · Diagnostics & Research
内部人信号
1 位买方 · 3 条买入交易行 · $1.0M 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
- ⚠ 角色得分低 · 买入者中职位最高的是：TenPercentOwner,Other（CEO、董事长和持股 10% 以上的股东得分最低）
- ⚠ Purchase activity is becoming less recent
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: TenPercentOwner,Other. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 52.3
- 52.2
- 52.2
- 52.0
- 51.9
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -0.1%
- 3M
- +21.5%
- 6M
- +98.2%
- 12M
- +235.7%
波动率与流动性
- 波动率
- 112.9%
- Beta
- —
- 平均每日成交额
- USD 2.6M
估值
- 市值
- USD 274.5M
- P/E
- —
基本面
- 利润率
- -39.9%
- ROE
- —
- 细分行业
- Diagnostics & Research
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, 利润率 · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-07-30 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 201,849
- 上期报告
- 214,006
- 日均成交量
- 109,841
- 回补天数
- 1.8
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-12 | SCHULER JACK W | 买入 (P) | Common Stock | 15,000 | USD 24.47 | USD 367,050 | SEC 申报 ↗ |
| 2026-08-11 | SCHULER JACK W | 买入 (P) | Common Stock | 13,700 | USD 24.01 | USD 328,937 | SEC 申报 ↗ |
| 2026-08-10 | SCHULER JACK W | 买入 (P) | Common Stock | 13,900 | USD 24.25 | USD 337,075 | SEC 申报 ↗ |
| 2026-01-26 | SCHULER JACK W | 买入 (P) | Common Stock | 20,000 | USD 11.80 | USD 236,000 | SEC 申报 ↗ |
| 2026-01-23 | SCHULER JACK W | 买入 (P) | Common Stock | 80,000 | USD 11.81 | USD 944,800 | SEC 申报 ↗ |
| 2026-01-22 | SCHULER JACK W | 买入 (P) | Common Stock | 82,465 | USD 10.96 | USD 903,816 | SEC 申报 ↗ |
| 2025-09-19 | SCHULER JACK W | 买入 (P) | Common Stock | 142,045 | USD 7.04 | USD 999,997 | SEC 申报 ↗ |
| 2025-09-18 | SCHULER JACK W | 买入 (P) | Common Stock | 3,056 | USD 6.17 | USD 18,856 | SEC 申报 ↗ |
| 2025-09-17 | SCHULER JACK W | 买入 (P) | Common Stock | 15,317 | USD 6.04 | USD 92,515 | SEC 申报 ↗ |
| 2025-08-29 | SCHULER JACK W | 买入 (P) | Common Stock | 3,488,372 | USD 0.43 | USD 1,500,000 | SEC 申报 ↗ |
| 2025-05-19 | SCHULER JACK W | 买入 (P) | Common Stock | 723,239 | USD 0.34 | USD 245,901 | SEC 申报 ↗ |
| 2025-05-16 | SCHULER JACK W | 买入 (P) | Common Stock | 4,000,000 | USD 0.27 | USD 1,080,000 | SEC 申报 ↗ |
| 2024-11-21 | SCHULER JACK W | 买入 (P) | Common Stock | 100,000 | USD 1.23 | USD 123,000 | SEC 申报 ↗ |
| 2024-11-21 | Kennedy Lawrence T. Jr | 买入 (P) | Common Stock | 35,000 | USD 1.16 | USD 40,600 | SEC 申报 ↗ |
| 2024-11-20 | SCHULER JACK W | 买入 (P) | Common Stock | 200,000 | USD 1.17 | USD 234,000 | SEC 申报 ↗ |
Form 4 申报证据
49 transaction lines in the latest 365-day window; 393 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | PATIENCE JOHN | 期权行权／转换 (M) | Common Stock | 1,360 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-12 | SCHULER JACK W | 买入 (P) | Common Stock | 15,000 | USD 24.47 | USD 367,050 | SEC 申报 ↗ |
| 2026-08-11 | SCHULER JACK W | 买入 (P) | Common Stock | 13,700 | USD 24.01 | USD 328,937 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | PATIENCE JOHN | 期权行权／转换 (M) | Common Stock | 1,360 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-12 | SCHULER JACK W | 买入 (P) | Common Stock | 15,000 | USD 24.47 | USD 367,050 | SEC 申报 ↗ |
| 2026-08-11 | SCHULER JACK W | 买入 (P) | Common Stock | 13,700 | USD 24.01 | USD 328,937 | SEC 申报 ↗ |
| 2026-08-10 | SCHULER JACK W | 买入 (P) | Common Stock | 13,900 | USD 24.25 | USD 337,075 | SEC 申报 ↗ |
| 2026-06-30 | PATIENCE JOHN | 期权行权／转换 (M) | Common Stock | 1,361 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-23 | Vazquez Chris | 卖出 (S) | Common Stock | 211 | USD 12.78 | USD 2,697 | SEC 申报 ↗ |
| 2026-02-23 | Pestano Gary Anthony | 卖出 (S) | Common Stock | 556 | USD 12.78 | USD 7,106 | SEC 申报 ↗ |
| 2026-02-23 | O'Kane Kieran | 卖出 (S) | Common Stock | 535 | USD 12.78 | USD 6,837 | SEC 申报 ↗ |
| 2026-02-23 | Hutton Scott | 卖出 (S) | Common Stock | 1,490 | USD 12.78 | USD 19,042 | SEC 申报 ↗ |
| 2026-02-23 | Cowie Robin Harper | 卖出 (S) | Common Stock | 535 | USD 12.78 | USD 6,837 | SEC 申报 ↗ |
| 2026-02-20 | Vazquez Chris | 期权行权／转换 (M) | Common Stock | 563 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-20 | Pestano Gary Anthony | 期权行权／转换 (M) | Common Stock | 1,528 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-20 | O'Kane Kieran | 期权行权／转换 (M) | Common Stock | 1,469 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-20 | Hutton Scott | 期权行权／转换 (M) | Common Stock | 4,844 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-20 | Cowie Robin Harper | 期权行权／转换 (M) | Common Stock | 1,469 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-10 | Vazquez Chris | 卖出 (S) | Common Stock | 101 | USD 10.08 | USD 1,018 | SEC 申报 ↗ |
| 2026-02-10 | Pestano Gary Anthony | 卖出 (S) | Common Stock | 540 | USD 10.08 | USD 5,443 | SEC 申报 ↗ |
| 2026-02-10 | O'Kane Kieran | 卖出 (S) | Common Stock | 584 | USD 10.08 | USD 5,887 | SEC 申报 ↗ |
| 2026-02-10 | Hutton Scott | 卖出 (S) | Common Stock | 3,559 | USD 10.08 | USD 35,875 | SEC 申报 ↗ |
| 2026-02-10 | Cowie Robin Harper | 卖出 (S) | Common Stock | 941 | USD 10.08 | USD 9,485 | SEC 申报 ↗ |
| 2026-02-09 | Vazquez Chris | 期权行权／转换 (M) | Common Stock | 263 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-09 | Pestano Gary Anthony | 期权行权／转换 (M) | Common Stock | 1,481 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-09 | O'Kane Kieran | 期权行权／转换 (M) | Common Stock | 1,600 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-09 | Hutton Scott | 期权行权／转换 (M) | Common Stock | 9,998 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-09 | Cowie Robin Harper | 期权行权／转换 (M) | Common Stock | 2,584 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-26 | SCHULER JACK W | 买入 (P) | Common Stock | 20,000 | USD 11.80 | USD 236,000 | SEC 申报 ↗ |
| 2026-01-23 | SCHULER JACK W | 买入 (P) | Common Stock | 80,000 | USD 11.81 | USD 944,800 | SEC 申报 ↗ |
| 2026-01-22 | SCHULER JACK W | 买入 (P) | Common Stock | 82,465 | USD 10.96 | USD 903,816 | SEC 申报 ↗ |
| 2026-01-16 | Vazquez Chris | 卖出 (S) | Common Stock | 83 | USD 8.15 | USD 676 | SEC 申报 ↗ |
| 2026-01-16 | Pestano Gary Anthony | 卖出 (S) | Common Stock | 298 | USD 8.15 | USD 2,429 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | BDSX |
| CIK | 0001439725 |
| 行业 | Healthcare |
| 细分行业 | Diagnostics & Research Yahoo Finance |
| SEC SIC | 8071 Services-Medical Laboratories |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 393 transaction lines from 2020-10-30 to 2026-09-30 81 P purchase lines · 134 S sale lines · 178 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.